documents: FDA-2018-N-3091-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2018-N-3091-0003 | FDA | FDA-2018-N-3091 | Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal | Notice | Notice of Renewal | 2022-12-13T05:00:00Z | 2022 | 12 | 2022-12-13T05:00:00Z | 2022-12-13T16:40:16Z | 2022-27014 | 0 | 0 | 0900006485532499 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref